| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥5.80B | ¥4.49B | +29.1% |
| Cost of Sales | ¥4.47B | ¥3.80B | +17.6% |
| Gross Profit | ¥1.33B | ¥693M | +92.5% |
| SG&A Expenses | ¥881M | ¥905M | -2.7% |
| Operating Income | ¥452M | ¥-212M | +313.2% |
| Non-operating Income | ¥56M | ¥34M | +64.7% |
| Non-operating Expenses | ¥5M | ¥17M | -70.6% |
| Ordinary Income | ¥503M | ¥-195M | +357.9% |
| Profit Before Tax | ¥588M | ¥-195M | +401.5% |
| Income Tax Expense | ¥123M | ¥-58M | +312.1% |
| Net Income | ¥465M | ¥-137M | +439.4% |
| Net Income Attributable to Owners | ¥465M | ¥-137M | +439.4% |
| Total Comprehensive Income | ¥555M | ¥-178M | +411.8% |
| Depreciation & Amortization | ¥171M | ¥236M | -27.5% |
| Interest Expense | ¥0 | - | - |
| Basic EPS | ¥57.27 | ¥-17.05 | +435.9% |
| Dividend Per Share | ¥7.50 | ¥7.50 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥9.94B | ¥9.04B | +¥891M |
| Cash and Deposits | ¥3.53B | ¥2.77B | +¥766M |
| Accounts Receivable | ¥2.49B | ¥2.10B | +¥387M |
| Inventories | ¥1.98B | ¥2.19B | ¥-213M |
| Non-current Assets | ¥4.53B | ¥3.60B | +¥925M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥991M | ¥94M | +¥897M |
| Investing Cash Flow | ¥-678M | ¥-171M | ¥-507M |
| Financing Cash Flow | ¥450M | ¥-62M | +¥512M |
| Free Cash Flow | ¥313M | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 8.0% |
| Gross Profit Margin | 23.0% |
| Current Ratio | 336.6% |
| Quick Ratio | 269.5% |
| Debt-to-Equity Ratio | 0.33x |
| EBITDA Margin | 10.7% |
| Effective Tax Rate | 20.9% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +29.2% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 8.62M shares |
| Treasury Stock | 451K shares |
| Average Shares Outstanding | 8.12M shares |
| Book Value Per Share | ¥1,328.08 |
| EBITDA | ¥623M |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥7.50 |
| Year-End Dividend | ¥5.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| FineChemical | ¥2.86B | ¥701M |
| FlameRetardants | ¥2.23B | ¥239M |
| HealthSupport | ¥714M | ¥61M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥10.35B |
| Operating Income Forecast | ¥300M |
| Ordinary Income Forecast | ¥360M |
| Net Income Attributable to Owners Forecast | ¥250M |
| Basic EPS Forecast | ¥30.93 |
| Dividend Per Share Forecast | ¥5.00 |
| Property, Plant & Equipment | ¥2.64B | ¥1.75B | +¥889M |
| Intangible Assets | ¥132M | ¥143M | ¥-11M |
| Investment Securities | ¥1.58B | ¥1.52B | +¥63M |
| Total Assets | ¥14.46B | ¥12.65B | +¥1.81B |
| Current Liabilities | ¥2.95B | ¥2.19B | +¥762M |
| Accounts Payable | ¥1.89B | ¥1.42B | +¥474M |
| Non-current Liabilities | ¥652M | ¥150M | +¥502M |
| Long-term Loans | ¥445M | - | - |
| Total Liabilities | ¥3.60B | ¥2.34B | +¥1.26B |
| Total Equity | ¥10.86B | ¥10.30B | +¥551M |
| Capital Stock | ¥300M | ¥300M | ¥0 |
| Capital Surplus | ¥3.44B | ¥3.45B | ¥-15M |
| Retained Earnings | ¥6.94B | ¥6.51B | +¥424M |
| Treasury Stock | ¥-327M | ¥-377M | +¥50M |
| Owners' Equity | ¥10.86B | ¥10.30B | +¥551M |
| Working Capital | ¥6.98B | - | - |